Cardiac Arrest vs Heart Attack. They Are Not the Same Thing.

These two terms are used interchangeably in common language and across most media coverage. They are not the same thing. The distinction is mechanistic, not semantic, and understanding it changes what you do in an emergency, what the clinical management looks like, and why the outcomes differ so dramatically between the two events.

The Mechanism

A myocardial infarction (heart attack) is a vascular occlusion event. The underlying cause in the vast majority of cases is atherosclerosis: lipid-rich plaques that build up in the intima of coronary arteries over years or decades. The acute event begins with plaque rupture or erosion. When a vulnerable plaque ruptures, the lipid core is exposed to circulating blood. Platelets adhere to the exposed collagen and lipid, aggregate, and trigger the coagulation cascade. Within minutes, a platelet-fibrin thrombus forms at the site of rupture. If that thrombus is large enough to occlude the artery, blood flow to the myocardium distal to the blockage stops.

What follows is a progression of ischemic injury. The myocardium is metabolically demanding tissue with minimal oxygen reserve. Within 20 minutes of complete occlusion, irreversible cell death begins in the subendocardium, the innermost layer of the heart wall where oxygen demand is highest and collateral flow is least. Over the next 1 to 6 hours, the wavefront of necrosis expands outward through the myocardial wall toward the epicardium. The final infarct size is determined primarily by two variables: the territory supplied by the occluded artery, and how long the occlusion persists before flow is restored.

This is the mechanistic basis for the phrase “time is muscle.” It is not metaphor. Every 30 minutes of additional ischemia translates to measurable incremental myocardial loss, impaired left ventricular function, and increased mortality.

Clinically, acute MI is classified by the electrocardiographic pattern at presentation. ST-elevation MI (STEMI) indicates complete occlusion of an epicardial coronary artery, with the characteristic finding of ST-segment elevation in the leads supplied by that artery. STEMI is a catheterization lab activation. The goal is door-to-balloon time, meaning the interval from hospital arrival to coronary artery reopening, within 90 minutes. Non-ST-elevation MI (NSTEMI) indicates partial occlusion or subtotal obstruction, with ECG findings of ST depression or T-wave changes but without frank ST elevation. NSTEMI carries high risk, but the approach is typically urgent rather than emergent catheterization within 24 to 72 hours depending on risk stratification.

Throughout all of this, the patient with a myocardial infarction remains conscious. The heart is still beating. The problem is regional, not global. The patient presents with chest pain or pressure, often radiating to the left arm, jaw, or back, frequently accompanied by diaphoresis, nausea, or shortness of breath. Symptoms may be atypical, particularly in women and patients with diabetes, who may present with fatigue, epigastric discomfort, or dyspnea without prominent chest pain.

Cardiac arrest is a categorically different event. It is not about blood supply to the myocardium. It is about the failure of the heart’s electrical system to generate coordinated mechanical contraction. The result is no cardiac output. Blood flow to every organ, including the brain, stops.

The most common arrhythmia producing cardiac arrest is ventricular fibrillation (VF): chaotic, disorganized electrical activity in the ventricles firing at 300 to 400 impulses per minute, producing quivering rather than contraction. Cardiac output drops to zero within seconds. Consciousness is lost within 10 to 15 seconds of VF onset as cerebral perfusion stops. Without defibrillation, VF may deteriorate to asystole, the complete absence of electrical activity, within minutes.

Three other rhythms also produce cardiac arrest. Pulseless ventricular tachycardia (pulseless VT) is a fast, organized ventricular rhythm that is mechanically ineffective because the ventricles do not fill adequately between beats. It is potentially more amenable to conversion than VF. Asystole is a flatline: no electrical activity, no mechanical activity, uniformly poor prognosis without a reversible cause. Pulseless electrical activity (PEA) is perhaps the most clinically counterintuitive: organized electrical activity appears on the monitor, but no pulse is present. PEA implies a mechanical reason the heart cannot generate output despite a functioning electrical system, such as tension pneumothorax, cardiac tamponade, massive pulmonary embolism, severe hypovolemia, or severe metabolic derangement. PEA demands a rapid search for and reversal of the underlying cause.

The distinguishing clinical feature is unambiguous: a person in cardiac arrest is unresponsive and pulseless. A person having a heart attack is typically conscious, in pain, and capable of calling for help.

Heart attack is one of the most common precipitants of cardiac arrest. The ischemic zone from coronary occlusion creates a heterogeneous electrical environment in the myocardium: areas with normal conduction adjacent to areas with slowed or blocked conduction. This heterogeneity creates the substrate for re-entrant arrhythmia circuits, which can degenerate into VF. Reperfusion, paradoxically, can also trigger arrhythmias as stunned myocardium resumes electrical activity unpredictably. But cardiac arrest can and does occur entirely independently of coronary artery disease. Structural heart diseases including hypertrophic cardiomyopathy and arrhythmogenic right ventricular cardiomyopathy (ARVC), primary electrical syndromes including long QT syndrome and Brugada syndrome, electrolyte abnormalities, and drug-induced QT prolongation all represent pathways to VF and cardiac arrest that bypass coronary occlusion entirely.

What the Evidence Shows

The mortality data for both conditions are substantial, and the survival curves are steep, particularly for cardiac arrest.

The Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO) trial, published in The New England Journal of Medicine in 1993, established early and complete coronary reperfusion as the determinant of survival benefit in STEMI. Topol and colleagues demonstrated that patients achieving TIMI grade 3 flow (complete, brisk coronary reperfusion) had a 30-day mortality of 4.4 percent, compared with 8.9 percent for those achieving only partial flow. The absolute difference was not trivial. It represented thousands of lives per year at scale. Subsequent data from the GRACE (Global Registry of Acute Coronary Events) registry, published by Fox and colleagues in JAMA in 2002 and updated in subsequent reports, quantified the gradient in ACS outcomes across risk strata and confirmed that delays to reperfusion, even within the door-to-balloon window, tracked with worse outcomes in a dose-response relationship.

For cardiac arrest, the critical number is minutes to defibrillation. Weisfeldt and Becker, writing in JAMA in 2002, formalized the three-phase temporal model of cardiac arrest: the electrical phase (approximately the first 4 minutes, during which defibrillation alone is effective), the circulatory phase (minutes 4 through 10, during which CPR to restore minimal perfusion before defibrillation improves outcomes), and the metabolic phase (beyond 10 minutes, during which outcomes are extremely poor regardless of intervention). The survival rate from out-of-hospital cardiac arrest in ventricular fibrillation drops by 7 to 10 percent per minute without defibrillation. This is not a minor gradient. At 10 minutes without defibrillation, survival from VF approaches zero.

The Oregon Sudden Unexpected Death Study (Oregon SUDS), a prospective population-based study led by Chugh and colleagues at the Cedars-Sinai Heart Institute and published in Circulation in 2004 and subsequent follow-up reports, documented the epidemiology of sudden cardiac arrest in a defined population. The data consistently showed that out-of-hospital cardiac arrest survival to hospital discharge in unselected populations remained below 10 percent, even in well-resourced EMS systems. The gap between witnessed VF survival (where bystander CPR and early defibrillation can push survival above 30 to 40 percent) and unwitnessed or non-VF arrest (where survival is often below 5 percent) underscores how much the outcome depends on the first few minutes.

The American Heart Association Chain of Survival data, synthesized across multiple prospective studies and summarized in the AHA 2020 Guidelines for CPR and Emergency Cardiovascular Care, identifies six links: recognition of cardiac arrest and activation of emergency response, immediate high-quality CPR, rapid defibrillation, advanced resuscitation, post-cardiac arrest care, and recovery. Each link has quantified impact. Bystander CPR doubles to triples the likelihood of survival from out-of-hospital cardiac arrest (OHCA). Deployment of public access AEDs, as demonstrated in the Hallstrom et al. study published in The New England Journal of Medicine in 2004, increased survival from VF in public locations to 49 percent when bystanders used an AED before EMS arrival, compared with 14 percent when they waited for EMS.

For acute MI, the GRACE registry data establish that across the ACS spectrum, in-hospital mortality for STEMI treated with primary PCI at high-volume centers is now consistently below 5 percent in unselected populations, down from historical rates exceeding 15 percent before the reperfusion era. The survival benefit depends on time. Every 30-minute delay in door-to-balloon time is associated with a 7.5 percent increase in one-year mortality, per the Cannon et al. analysis in Circulation in 2000.

What to Do This Week

1. Locate the nearest automated external defibrillator (AED) in your workplace, gym, place of worship, and any other building you frequent. AEDs are typically wall-mounted in clearly marked cases near main corridors or entryways. Knowing the location before an emergency removes a critical delay. If your workplace does not have one, raise it with facilities management: the cost of a public-access AED is now well under $2,000, and OSHA guidelines recommend them for worksites above a minimum size.

2. Complete a CPR certification course. The American Heart Association and American Red Cross both offer in-person and blended (online plus brief skills check) courses. Hands-only CPR, meaning compressions without rescue breaths, is the current recommended approach for untrained bystanders and is highly effective. The course takes roughly 2 hours for the basic certification. If you are the family member or close contact of someone with known cardiovascular disease, heart failure, or prior MI, this is not optional preparation. It is specific preparation for a plausible scenario.

3. Know the aspirin protocol for suspected heart attack. If you or someone nearby develops symptoms consistent with MI (chest pressure, radiating arm or jaw pain, diaphoresis, sudden shortness of breath), call 911 first, then chew one adult aspirin (325 mg) if the person is not allergic and is not already taking anticoagulants. Chewing rather than swallowing accelerates absorption. The platelet-inhibiting effect begins within minutes and can reduce thrombus propagation. This is a standard pre-hospital recommendation from both the AHA and the American College of Cardiology, but confirm the specific guidance with your physician given individual medication interactions.

4. Document your personal cardiovascular risk factors and current medications in a format accessible to emergency personnel. A medical ID card in your wallet, a note in your phone’s emergency contact screen, or a medical alert bracelet gives paramedics the information they need in the first minutes of a cardiac emergency. Include: any prior MI or cardiac arrest, any implanted device (pacemaker or ICD), current anticoagulant medications, known allergies to contrast or medications, and your cardiologist’s name and number. This information changes clinical decision-making within the first 5 minutes of emergency contact.

5. If you have established coronary artery disease, heart failure, a prior MI, or a family history of sudden cardiac death before age 50 in a first-degree relative, schedule a direct conversation with your cardiologist about your specific arrhythmia risk. Ask directly whether your case warrants evaluation for ICD placement, whether your current medications are optimized for arrhythmia prevention, and what warning symptoms should prompt an immediate 911 call rather than a call to the clinic. This is not a conversation to defer to your next annual visit if these risk factors apply to you.

The two conditions share anatomy but not mechanism. A heart attack is a blocked coronary artery with the heart still beating and time to act measured in hours. Cardiac arrest is a failed electrical system with blood flow to the brain stopped and time to act measured in minutes. Knowing which one you are facing, and what to do about it, is the entire point.